TY - JOUR AU - Sevilla-González, Magdalena del Rocío AU - Merino, Jordi AU - Moreno-Macias, Hortensia AU - Rojas-Martínez, Rosalba AU - Gómez-Velasco, Donají Verónica AU - Manning, Alisa K. PY - 2021 DA - 2021/02/27 TI - Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk JO - Cardiovascular Diabetology SP - 56 VL - 20 IS - 1 AB - Impaired fasting glucose (IFG) is a prevalent and potentially reversible intermediate stage leading to type 2 diabetes that increases risk for cardiometabolic complications. The identification of clinical and molecular factors associated with the reversal, or regression, from IFG to a normoglycemia state would enable more efficient cardiovascular risk reduction strategies. The aim of this study was to identify clinical and biological predictors of regression to normoglycemia in a non-European population characterized by high rates of type 2 diabetes. SN - 1475-2840 UR - https://doi.org/10.1186/s12933-021-01246-1 DO - 10.1186/s12933-021-01246-1 ID - Sevilla-González2021 ER -